Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.

Purpose: To evaluate refractive error in infants who underwent intravitreal bevacizumab injection for treatment of threshold retinopathy of prematurity (ROP).

Design: Retrospective nonrandomized interventional comparative study.

Methods: The study group included all infants who consecutively received a single intravitreal bevacizumab (0.